mechanism 1,313 words KG: Nitric Oxide Signaling in 4R-Tauopathies 2026-04-01
kind:section:mechanismsevidence:strongmechanismsection:mechanismsstate:published4r-tauopathynitric-oxidenitrosative-stresspspcbdftdp-17
Contents

Nitric Oxide Signaling in 4R-Tauopathies

Mechanism Info
NameNitric Oxide Signaling in 4R-Tauopathies
SummaryCross-disease mechanism page comparing nitric oxide signaling dysregulation across PSP, CBD, AGD, GGT, and FTDP-17. Covers nNOS, eNOS, iNOS expression, NO signaling in synaptic plasticity, nitrosative stress, protein S-nitrosylation, peroxynitrite formation, and therapeutic implications.

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Smartphone-Detected Motor Variability Correction
Score: 0.56

Related Analyses (30)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (15)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40